# ENFUEGO THERAPEUTICS INC.: Overcoming Adaptive KRAS Inhibitor Resistance with Ligand-Directed KRAS G12V-panTEAD Chimeras

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | ENFUEGO THERAPEUTICS INC. |
| Location | PITTSBORO, NC |
| Project | Overcoming Adaptive KRAS Inhibitor Resistance with Ligand-Directed KRAS G12V-panTEAD Chimeras |
| Project number | 1R44CA314597-01 |
| Mechanism | R44 |
| Institute | National Cancer Institute |
| Award | $311,734 |
| Awarded | 2026-09-14 |
| Project period | 2026-09-14 to 2027-08-31 |
| UEI | N4XYELPNM224 |

## Why this score
- Award of $311,734.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11407293). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.